Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05100589 · ClinicalTrials.gov registry record · NA
Effect of PeakATP on Mood, Reaction Time and Cognition
A NA study of Cognitive Change and Mood, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT05100589 is a NA study of Cognitive Change and Mood that has completed, run by University of Central Florida. The registered enrollment target is 35 participants, below the 179-participant average among 44 other Cognitive Change trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05100589, a NA study of Cognitive Change and Mood, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Oral ATP disodium (adenosine 5'- triphosphate disodium) is a commercially available product available alone and as a constituent in a number of sports supplements that is purported to maintain ATP levels and improve performance during high-intensity exercise. Acute deficits in cognitive performance have also been reported in both young adults and children following high-intensity exercise; however, the effects of supplemental ATP on cognitive performance has not been studied. Goals: 1. To investigate the effect of ATP supplementation versus. placebo on mood, reaction time and cognitive performance before and after an acute bout of fatiguing exercise. 2. To investigate the effect of ATP supplementation versus. placebo on anaerobic performance.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT PeakATP
Study Locations (1)
Florida
- Kinesiology Research Labs - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2022-04-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05100589
The ClinicalTrials.gov registry entry for NCT05100589 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 44 other Cognitive Change trials with a reported enrollment target (80% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cognitive Change appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05100589 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05100589 about?
NCT05100589 is a clinical study titled "Effect of PeakATP on Mood, Reaction Time and Cognition". Oral ATP disodium (adenosine 5'- triphosphate disodium) is a commercially available product available alone and as a constituent in a number of sports supplements that is purported to maintain ATP levels and improve performance during high-intensity exercise. Acute deficits in cognitive performance ...
What is the current status of trial NCT05100589?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2021-10-06. Estimated completion is 2022-04-19.
What conditions does trial NCT05100589 study?
This clinical trial studies the following conditions: Cognitive Change, Mood.
What interventions are being tested in trial NCT05100589?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), PeakATP (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05100589?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05100589 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Change
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Moderators and Mediators of Perceptual Learning
RECRUITING · NA
-
Amplitude Titration to Improve ECT Clinical Outcomes
RECRUITING · NA
-
The Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young Adults
RECRUITING · NA
-
Remote Evaluation of MIND Diet
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.